Yolk Antibody + Iiaprazole + Amoxicillin + Clarithromycin + Furazolidone + Doxycycline

This appears to be a complex combination therapy regimen intended for the eradication of *Helicobacter pylori* infection. The combination includes multiple antibiotics (amoxicillin, clarithromycin, furazolidone, doxycycline), a proton pump inhibitor (iiaprazole, which may be a less common spelling or regional variant of a PPI like ilaprazole or lansoprazole/omeprazole depending on context), and yolk antibody (likely a preparation of immunoglobulins derived from egg yolk). Based on the search results, this exact combination is not specifically mentioned as a single formulation or widely documented regimen. However, the individual components (antibiotics and PPIs) are commonly used in various *H. pylori* eradication protocols, particularly multi-drug regimens like quadruple therapy, often employed in regions with high antibiotic resistance. Furazolidone and doxycycline, for instance, are alternatives used when standard therapies fail or resistance is high. The role of yolk antibody in this specific combination is not detailed in the search results, but such preparations are sometimes explored as supplementary agents or in functional foods for managing infections, possibly aiming to bind or neutralize the pathogen or its toxins.